Retrospective review of seven patients with obesity simultaneously treated with a combination of a glucagon-like peptide-1 receptor agonist and a meal replacement product
MRPs can be initiated concomitantly with a GLP-1 RA for weight management. This might enhance weight-loss effectiveness, with potential additional benefits that should be elucidated in further and larger studies.
Authors
- Odd Erik Johansen (ORCID: https://orcid.org/0000-0003-2470-0530)
- Catherine Bacus
- Sonia Raudszus
- Terri-Lynne South
Institutions
- Zuid-Afrikaans Hospital (ZA)
- Nestlé (Switzerland) (CH)
- Washington Center for Weight Management and Research (US)
- Australian Catholic University (AU)
Publication Details
- Journal
- Obesity Pillars
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1016/j.obpill.2024.100138
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.36